Retail medicine, and what it leaves out
Brandon is a retail town before it is anything else, and the certification storefronts fit that character perfectly. Walk in, hand over a flat fee, answer a few questions, walk out with a registry entry. The whole transaction is engineered to feel like getting a key copied.
Convenience is real, and so is everything the model skips. Fifteen minutes leaves no room to reconcile a medication list, and cannabis has documented interactions worth taking seriously. It leaves no room to ask whether the back pain behind the visit has ever been imaged, or whether the anxiety being described is actually untreated PTSD that deserves trauma-focused care in its own right. A storefront that only sells certifications has no reason to raise any of that, because raising it slows the line down.
We built this service inside a family medicine practice on purpose. Dr. Saylor's daily work is chronic disease management, so the certification sits inside a fuller clinical picture: your other diagnoses, your other prescriptions, and our psychiatry and talk therapy teams when the qualifying condition is psychiatric. Sometimes the fuller picture ends with a recommendation. Sometimes it ends with a candid explanation of why cannabis isn't the right tool for you yet. Both are legitimate outcomes of a real evaluation.
The conditions where that context earns its keep are the ones we see most. Chronic pain tied to a qualifying condition pairs with non-cannabis pain management rather than replacing it. PTSD certification tends to be more useful when trauma-focused care is running alongside it, which is why our talk therapy and psychiatric teams stay involved. Cancer-related nausea, appetite loss, and pain get coordinated with your oncologist. Crohn's disease stays a gastroenterology problem, and multiple sclerosis and Parkinson's stay neurology problems, with cannabis playing whatever supporting role the evidence and your specialists support.
What Florida law requires before any card shows up
Section 381.986 of the Florida Statutes sets the whole structure. Only a physician registered with the state's Office of Medical Marijuana Use (OMMU) as a qualifying physician can evaluate you, and only for the specific conditions the statute names. When the physician finds the criteria met, the recommendation is entered into the Compassionate Use Registry. That entry is not a prescription. Cannabis remains a Schedule I controlled substance under federal law, which means no physician in the country can legally prescribe it. What Florida permits is a state-regulated recommendation, and the distinction matters for insurance, for pharmacies, and for how the visit gets billed.
The first evaluation must happen face to face. Current Florida law gives no fully remote path to an initial certification, so any website promising a same-day card with no office visit is describing something the statute doesn't allow for new patients. After the registry entry, you apply to the OMMU for the state ID card and pay the state's application fee directly to them. Processing typically runs a few weeks. Card in hand, you can purchase from any licensed Medical Marijuana Treatment Center in Florida, and the choice of dispensary is entirely yours. Our role ends at the clinical evaluation and the registry entry, which is exactly where the statute draws the physician's line.
The qualifying conditions list, straight
At the time of this writing, the statute names cancer, epilepsy, glaucoma, HIV/AIDS, post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Crohn's disease, Parkinson's disease, multiple sclerosis, medical conditions of the same kind or class as those listed, terminal conditions diagnosed by a physician other than the qualifying physician, and chronic nonmalignant pain caused by or originating from a qualifying condition. Florida revises its cannabis rules periodically, so we verify your eligibility against the current statute at the visit itself rather than against a webpage.
A few of these deserve translation. PTSD needs a documented diagnosis, not just symptoms; if you've never had a formal psychiatric evaluation, that step comes first, and it's one our own psychiatric team can provide. Chronic pain does not qualify on its own. The statute requires the pain to be caused by or to originate from a listed condition, which is why the records connecting the two carry so much weight. The "same kind or class" clause is a case-by-case physician judgment, not an open door. And the terminal-condition pathway requires a second physician's diagnosis before the qualifying physician can act on it.
Reading the file before reading the patient
Plan for 30 to 45 minutes at the Tampa-Carrollwood office. Bring whatever documents your qualifying condition: specialist notes, imaging reports, prior medication trials, related diagnoses. Those records do real work at this appointment, because the statute ties eligibility to documentation, not to how convincingly symptoms are described.
Dr. Saylor reviews your history and current medications, then talks through what the research actually shows for your specific condition, which side effects and interactions to watch, what the state ID-card process looks like from here, and which alternatives might make sense alongside cannabis or instead of it. Nothing about cannabis makes it a starting point; in most situations it earns consideration after standard treatments have been tried or while they continue. If the evaluation supports certification, the recommendation can often go into the Compassionate Use Registry during that same visit.
And if it doesn't support certification, you'll hear that plainly, along with what's missing and what we'd suggest instead. We would rather lose a certification fee than enter a recommendation the documentation can't carry.
One more thing a real medical practice does that a kiosk can't: when cannabis intersects with the rest of your medication management, we coordinate with the other prescribers involved. A cannabinoid added to a complicated regimen isn't a private matter between you and a dispensary. Your cardiologist, your psychiatrist, and your pain specialist can often manage you better when they know it's in the mix, and looping them in is part of how we run the follow-up side of this program.
What the research supports, and where it goes quiet
The most rigorous single summary of cannabis evidence is still the National Academies of Sciences 2017 consensus report. It found substantial evidence that cannabis or cannabinoids can help chronic pain in adults and reduce nausea and vomiting from chemotherapy, and moderate evidence for improving spasticity in multiple sclerosis. Beyond those, the report found limited or insufficient evidence for many of the uses that get advertised loudest, and it flagged how thin the long-term outcome data is across the board. For PTSD specifically, the research remains genuinely mixed, which is a strange fact to reconcile with how heavily PTSD certification gets marketed.
The regulatory picture deserves the same bluntness. The FDA has not approved cannabis as a treatment for any condition, and the plant remains Schedule I federally. The single FDA-approved cannabis-derived prescription drug is a purified CBD product for certain rare seizure disorders, and it is not what Florida dispensaries sell. Individual responses vary widely, side effects are real, and no honest clinic can guarantee approval or benefit. Any office that promises either is telling you about its sales process, not your prognosis.
Impairment, firearms, and work: the card's fine print
The legal costs of a card get less airtime than the medical questions, and they shouldn't. Florida's DUI statute prohibits operating a vehicle while impaired by any controlled substance, cannabis included, and a medical card is not a defense to that charge. Federal firearm law is stricter still: under 18 U.S.C. § 922(g)(3) a user of a controlled substance may not purchase or possess a firearm, and ATF Form 4473 asks about marijuana use directly, with no exception for state medical cards. Employment is the third pressure point. Florida's law does not require employers to accommodate medical cannabis, so a valid card may not protect you from the consequences of a positive drug test, particularly in safety-sensitive or federally contracted roles.
None of this means a card is a mistake when your condition qualifies and the evidence is on your side. It means the decision has more moving parts than a storefront visit acknowledges, and they belong in the conversation before you apply, not after. These evaluations are for adults 18 and older, and this page is informational only, not legal advice.
Who bills you, and for what
Because cannabis is federally Schedule I, insurers generally decline to reimburse anything tied to certification, regardless of what Florida law permits. Expect the evaluation to be self-pay. There are two separate fees to understand, and storefront advertising tends to blur them together: the clinical evaluation fee paid to the practice, which our billing team will confirm when you call (813) 670-3331, and the state ID-card application fee, which goes directly to the OMMU and is never part of our visit charge.
One nuance works in your favor. When your qualifying condition itself needs medical management, a chronic pain workup or a PTSD evaluation for instance, that underlying care can sometimes be billed to insurance as its own visit, separate from the certification. It's worth asking about when you call, because it's the kind of distinction a certification-only storefront has no reason to offer.
Who this is not for, and what we do instead
Most pages about certification describe the patients who qualify. The more useful list is the other one, because a storefront has no incentive to publish it and because being told "not you, and here is why" is a real clinical service rather than a failure of the appointment. Several groups come through this evaluation and leave with something other than a registry entry.
The first is the patient whose symptom is genuinely disabling but has never been worked up. Pain that has never been imaged, fatigue that has never had labs, neurological symptoms that have never seen a neurologist. Certifying that patient does two things at once: it puts a cannabinoid in front of an undiagnosed problem, and it removes the pressure that would otherwise have found the diagnosis. What happens instead is a referral, usually back into primary care or out to the specialty that should have seen it first.
The second is the patient whose real problem is psychiatric and undertreated. Someone describing what they call anxiety, who on a careful history has an untreated trauma history, or a mood disorder, or a substance pattern that a cannabinoid will complicate rather than relieve. That referral goes to our own psychiatry and talk therapy teams, which is one of the practical arguments for having this evaluation inside a full practice rather than a single-service office.
The third is the patient for whom cannabis carries a specific risk that outweighs the case for it. A personal or strong family history of psychosis, an active pregnancy, an unstable cardiac picture, or a medication regimen with interactions serious enough to make the addition unwise. Age matters here too. These evaluations are for adults 18 and older, and in older patients the falls-and-sedation question is a real part of the calculation rather than a formality.
The fourth is simpler and more common than the other three: the patient whose condition may well qualify but whose record does not yet show it. That is not a no. It is a not-yet, with a specific list of what would change the answer, and it is the outcome most likely to end with a phone call to a records office rather than a referral anywhere.
In every one of these cases the visit still produces something. A documented history, a reason, a next step, and where appropriate a referral with a name on it. We would rather send a patient somewhere more useful than enter a recommendation the record cannot carry, and we say so at the visit rather than by letter afterward.
Documentation is the whole ballgame, and Brandon has plenty of it
Brandon sits inside a dense stretch of eastern Hillsborough medicine. Between the hospital campus, the specialty groups clustered around it, and the imaging centers serving the east side, most patients here have already been seen for the condition they want certified. What they usually have not done is gather the paperwork that proves it.
That gap matters more than people expect, because Florida ties certification to a documented qualifying condition rather than to a reported symptom. A patient who has lived with a problem for a decade and a patient with a decade of records describing it are in different positions under the statute, even though they are the same person clinically. The second one can be certified. The first one has an errand to run first.
So the most useful thing this page can tell a Brandon reader is unglamorous: start the records request before you book the appointment. It is the step that most often decides whether the visit ends in a decision or a continuation, and it is entirely in your control.
What we do when the record and the story disagree
Sometimes the chart says less than the patient does, and sometimes it says something different. Neither is unusual, and neither is treated as a credibility problem. Records are written for the purpose of the visit that generated them, and a note dictated during an acute episode is not trying to establish a chronic diagnosis.
What happens in those cases is a conversation, not a rejection. We work out what is actually documented, what is missing, and whether the missing piece is reachable. Sometimes it is one phone call to a specialist's office. Sometimes it is a workup that has genuinely never been done, in which case the certification question is premature and the more important finding is the one nobody had looked for.
Related care and neighboring areas
- The medical marijuana program: the full program page behind this one
- Valrico certification: next door, with more depth on pain documentation
- Riverview certification: for patients south of the Alafia
- PTSD evaluation and treatment: what a formal diagnosis involves
- Talk therapy: the care that often runs alongside a certification
- Psychiatry: diagnostic clarity and medication management
FAQs about medical marijuana evaluation in Brandon
What are Florida's qualifying conditions?
Florida law lists specific qualifying conditions, including cancer, epilepsy, glaucoma, HIV/AIDS, PTSD, ALS, Crohn's disease, Parkinson's disease, multiple sclerosis, medical conditions of the same kind or class, terminal conditions, and chronic nonmalignant pain caused by or originating from a qualifying medical condition. The list can change as state law evolves; we confirm eligibility at your evaluation based on current statute.
Where is the Brandon evaluation done?
The initial Compassionate Use Registry evaluation is done in-person per Florida law at our Tampa-Carrollwood office (3971 Moran Road, Suite 101, Tampa, FL 33618). Ascend has no office in Brandon. Follow-up visits can often be done via telehealth.
Which records actually matter for a certification visit?
The ones that establish the diagnosis and show what has already been tried. A specialist's consultation note, imaging that documents the underlying problem, and a medication history showing prior treatment attempts do more for the decision than a long list of appointments. For a psychiatric qualifying condition, the formal diagnostic evaluation is the document that matters.
How do I request records from a Brandon specialist?
Most practices around the Brandon hospital campus have a medical records office and a release form, and turnaround is commonly one to two weeks. Ask for the consultation notes and any imaging reports rather than a visit summary. If you are not sure who holds what, call us and we can usually work it out from the treatment history you describe.
Can Ascend request the records on my behalf?
Often, yes, with your written authorization. It is worth starting that before you book so the request and the appointment are not racing each other. Bring whatever you already have in hand regardless, because a patient-held copy is frequently faster than an office-to-office request.
My PTSD was diagnosed years ago. Does that still count?
An older diagnosis is not automatically disqualifying, but it does have to be a formal diagnosis rather than a self-assessment, and the clinical picture has to be current enough to reason about. If the original evaluation is old and nothing has been documented since, we may recommend a fresh psychiatric evaluation before making a registry decision.
What if my only documentation is from an urgent care visit?
Then it probably is not enough on its own. Urgent care notes tend to record a complaint and a short-term plan rather than establish a chronic diagnosis, which is the thing the statute turns on. That is a common situation and it is fixable, usually by getting the condition properly evaluated first. We will say so plainly rather than certifying around a gap in the record.
Does certification change what my other doctors prescribe?
It can, and that is exactly why the conversation belongs inside a medical practice. Cannabis interacts with sedatives, blood thinners, and several psychiatric and seizure medications, so your full medication list gets reviewed at the evaluation and any concerns get discussed with you directly. We do not change another physician's prescribing, but we will tell you when something warrants a conversation with them.
Sources
- Florida Statute § 381.986 (medical use of marijuana); Florida Department of Health rule Chapter 64-4, F.A.C.
- Florida Office of Medical Marijuana Use (OMMU), patient registry and ID card guidance
- National Academies of Sciences, Engineering, and Medicine (2017). The Health Effects of Cannabis and Cannabinoids.
- FDA: cannabis-derived drug approvals and cannabis regulatory status
- 18 U.S.C. § 922(g)(3); ATF Form 4473
Medical cannabis is regulated under Florida Statute §381.986 and is not approved by the FDA for the treatment of any condition. The clinical evidence varies substantially by condition. Side effects and drug interactions exist and are discussed during evaluation. Cannabis remains a federally controlled Schedule I substance. This page is informational and does not substitute for a clinical visit. See Fla. Stat. § 381.986 and the Florida Department of Health, Office of Medical Marijuana Use (Chapter 64-4, F.A.C.).